Exact Therapeutics AS

Exact Therapeutics AS Net Debt per Share

The Net Debt per Share of Exact Therapeutics AS (EXTX.OL) as of Oct 22, 2026 is -1.57 NOK. In the previous year, Net Debt per Share was -0.72 NOK — a change of 117.30% (lower).

Net Debt per Share

-1.57NOK

YoY

117.30%

Last updated:

Net Debt per Share of Exact Therapeutics AS is 2024 -1.57 NOK. Net Debt per Share of Exact Therapeutics AS was 2023 -0.72 NOK. It decreases by 117.30% lower compared to the previous year.

The Exact Therapeutics AS Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2017
-0.24 NOK
Jan 1, 2018
-0.93 NOK
Jan 1, 2019
-0.71 NOK
Jan 1, 2020
-2.52 NOK
Jan 1, 2021
-1.62 NOK
Jan 1, 2022
-1.08 NOK
Jan 1, 2023
-0.72 NOK
Jan 1, 2024
-1.57 NOK
The Exact Therapeutics AS Net Debt per Share history
YEARNet Debt per ShareYoY
-1.57NOK+117.30%
-0.72NOK-32.87%
-1.08NOK-33.36%
-1.62NOK-35.81%
-2.52NOK+254.29%
-0.71NOK-23.30%
-0.93NOK+287.26%
-0.24NOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Exact Therapeutics AS Stock analysis

What does Exact Therapeutics AS do? Exact Therapeutics AS develops ACT sonoporation, a platform for ultrasound-mediated targeted drug enhancement to amplify therapeutic agents' clinical utility across cancer, infectious diseases, and neurological conditions. The company monetizes through research and development services for pharmaceutical partners seeking to enhance existing drug therapies with ultrasound targeting. Its primary customers are biopharmaceutical firms aiming to improve chemotherapy, immunotherapy, and other treatments. The firm's purpose centers on extending patient lives through targeted therapeutic enhancement using ultrasound and ACT formulation. Exact Therapeutics AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Exact Therapeutics AS stock

Net Debt per Share of Exact Therapeutics AS is -1.57 NOK in 2024.

Net Debt per Share of Exact Therapeutics AS changed from -0.72 NOK to -1.57 NOK, representing a 117.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Exact Therapeutics AS since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Exact Therapeutics AS

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Exact Therapeutics AS